Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation

por Jacobs, Maartje S., de Jong, Lisa A., Postma, Maarten J., Tieleman, Robert G., van Hulst, Marinus
Publicado 2017

Incidence, treatment and mortality of new-onset atrial fibrillation patients at the intensive care unit

por Jacobs, Maartje S, Loef, Bert, Reidinga, Auke C, Postma, Maarten J, Van Hulst, Marinus, Tieleman, Robert G
Publicado 2020

Health economic evaluation of nation-wide screening programmes for atrial fibrillation in the Netherlands

por van Hulst, Marinus, Tieleman, Robert G, Zwart, Lennaert A R, Pomp, Marc, Jacobs, Maartje S, Meeder, Joan G, van Ofwegen-Hanekamp, Clara E E, Hollander, Monika, Smits, Paul, Hemels, Martin E W
Publicado 2022